Omega Therapeutics, Inc. (OMGA) has a consensus analyst rating of Buy, based on 7 analysts covering the stock. Of those, 6 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for OMGA is $9.00, representing a +6,211.4% upside from the current price of $0.1426. Price targets range from a low of $7.00 to a high of $11.00.
